Top Section/Ad
Top Section/Ad
Most recent
Investors eye 2028, 2031, 2032 as big years for loan maturities
Even leveraged deals still being underwritten, though banks are selective
Liquidity event at American manager comes at fraught time for industry
Major sectors in leveraged loans are trading down, making shrewd credit selection vital
More articles/Ad
More articles/Ad
More articles
-
Goldman Sachs has given new titles to leaders in its credit finance, investment grade capital markets and equity capital markets businesses. -
Bain Capital has hired a new global head of ESG with extensive experience of oil and gas investments.
-
India’s Glenmark Pharmaceuticals has returned to the loan market after an absence of more than 10 years. It is seeking a $175m deal.
-
Goldman Sachs has named new global M&A bosses, with the incumbents moving to become chairs of the business.
-
German hospital operator Asklepios Kliniken launched a Schuldschein on Monday with an initial target of €200m. Investors have doubled down on their interest in pharmaceutical firms this year and throughout the pandemic, prompting a substantial increase in the market’s exposure to the sector.
-
Spanish telecoms group MasMovil is preparing a €720m bond, the second part of the financing for its take-private by Cinven, KKR and Providence Private Equity. Most of the €2.9bn financing came through a loan issue, allocated in July, with the bonds readied following shareholder acceptance for the offer last week.
